World Health Organization defends Covid-19 drug study after remdesivir maker Gilead questions methodology

• Research has raised questions about whether the antiviral, which was one of the drugs given to Donald Trump, is any use in treating the disease
• Chief statistician in study says the scale of the latest study means it is more representative than previous research